Oroxylin A suppresses the development and growth of colorectal cancer through reprogram of HIF1α-modulated fatty acid metabolism

Ting Ni(Soochow University), Libin Wei(China Pharmaceutical University)

Cell Death and Disease

June 8, 2017

10.1038/cddis.2017.261

Cited by 87

Related Papers

PfSETvs methylation of histone H3K36 represses virulence genes in Plasmodium falciparum

|Nature|2013|268

Novel loci and pathways significantly associated with longevity

|Scientific Reports|2016|203

RETRACTED ARTICLE: Oroxylin A activates PKM1/HNF4 alpha to induce hepatoma differentiation and block cancer progression

|Cell Death and Disease|2017|70

Oroxylin A promotes PTEN-mediated negative regulation of MDM2 transcription via SIRT3-mediated deacetylation to stabilize p53 and inhibit glycolysis in wt-p53 cancer cells

|Journal of Hematology & Oncology|2015|67

Novel CDK9 inhibitor oroxylin A promotes wild-type P53 stability and prevents hepatocellular carcinoma progression by disrupting both MDM2 and SIRT1 signaling

|Acta Pharmacologica Sinica|2021|51